News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Joe Y. Chang on upcoming PTCOG 63: IMRT vs IMPT Phase III trials
Joe Y. Chang/X
May 21, 2025, 18:49

Joe Y. Chang on upcoming PTCOG 63: IMRT vs IMPT Phase III trials

Joe Y Chang, Professor, Clinical Section Chief at MD Anderson Cancer Center, shared a post on X:

“Join us at PTCOG 63 to explore cutting-edge particle therapy and novel Phase III randomized studies comparing IMRT and IMPT.
With advancements in LET optimization, immune modulation, we are moving PT into the new era.”

PTCOG 63

More posts featuring Joe Y Chang on OncoDaily.

cancer IMPT IMRT Joe Y Chang MD Anderson Cancer Center OncoDaily Oncology PTCOG 63
Special Coverage
Voices
Aug 21, 2025, 23:33
Ohio State Launches Groundbreaking First-in-Human Cancer Drug Trial
Societies
Aug 21, 2025, 23:08
Empowering Cancer Survivors Through the Believe In You Program - Sylvester Comprehensive Cancer Center
Insight
Aug 21, 2025, 20:26
Kevin Harrington Looks Forward to CONCORDE Study Results on DNA Damage Inhibitors and Radiotherapy
Voices
Aug 21, 2025, 20:00
Raymond Mailhot: Advancing Hodgkin Lymphoma Survivor Study with NCI Funding
Voices
Aug 21, 2025, 19:28
Parvati Tiwari: Advocates Express Alarm Over NCI’s Decision to End PBTC Funding for Pediatric Brain Tumor Trials
Insight
Aug 21, 2025, 19:11
Maria Tolia: Exploring Regional Nodal Irradiation in Node-Positive Breast Cancer
Voices
Aug 21, 2025, 18:25
Strengthening Academic Writing in Oncology Nursing - European Oncology Nursing Society
Voices
Aug 21, 2025, 15:59
George Kumar: The interplay Between Cardiovascular Disease (CVD) and Cancer
Voices
Aug 21, 2025, 15:47
European Society of Gynaecological Oncology Announces that Applications are Open for Editor-in-Chief of IJGC
Insight
Aug 21, 2025, 15:37
Carolina Reduzzi: ctDNA Landscape Analysis Post CDK4/6 Inhibitor in HR+/HER2- Metastatic Breast Cancer
Voices
Aug 21, 2025, 15:30
Clinician-Scientists Awarded NMRC Transition Awards for Precision Lung Cancer Research - National Cancer Centre Singapore
Voices
Aug 21, 2025, 15:22
Construction of the $658 million Sydney Children’s Hospital Stage One and MCCCC Project Has Reached Completion